Skip to content
★ Sign in to follow
메디

메디포스트 Stock: price and insider trades · South Korea

KR·Mcap ₩316.2BHealth Care

No insider purchase over the last 90 days. The latest, by 마블2022홀딩스, was filed 20 Jan 2026.

메디포스트: what insiders have been doing

Every trade that managers of 메디포스트 disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. 5 insiders have disclosed 5 filings since 1 November 2025.

The record shows 3 purchases on the open market, made by 3 insiders, against 1 sale by 1 insider. The totals exclude 4 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

Compared with its exchange (2,655 companies, median 7 filings), a count of 5 filings is below the norm. Looking back to 2021, when coverage begins, insiders filed 15 purchases and 42 sales.

The clock since the last published purchase (20 January 2026) now reads 294 days. Typically, a trade is published a median of 7 days after it takes place. This delay matters because a trade only becomes useful information once it is public.

In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.

Insider Decl.
67
Thresholds
n/a
Buy Volume
€121M
15 ops. · all time
Sell Volume
€2,095
42 ops. · all time

Who traded when

BuySale
양윤선3 sales
마블2022홀딩스1 buy1 sale
스카이메디1 buy1 sale
엔에이치우리뉴딜그로쓰알파제1호사모투자1 buy

Since the insiders bought

  • Filed 10 Jan 2023 · 1400 days ago · €556k
    -31.8%
    Entry ₩12,703 · Close at T+365 ₩8,660

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩8,090
Analyst consensus
·
Income statement
Revenue₩73.7B
Gross profit₩45.4B62% margin
EBITDA-₩79.4B-108% margin
Net income-₩85.4B-115.9% margin
Balance sheet & cash
Market cap₩316.2B
Total debt₩40.4B
Free Cash Flow-₩60.4B
Last declaration on 12 March 2026
Declarations68 total
  • Other
    Other(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    Related company / holdingExecutives
    0DART
    21,290,073 sharesKRXDART:20260120000182
    Canonical exit: 13 Apr 2026 (T+90)
  • ▲
    Executives
    0DART
    24,070,786 sharesKRXDART:20260113000733
    Canonical exit: 6 Apr 2026 (T+90)
  • ▼
    Executives
    0DART
    18,509,361 sharesKRXDART:20260113000742
  • ▲
    €29.9Mest.0DART
    3,058,783 sharesKRXDART:20260107000318
    Canonical exit: 30 Mar 2026 (T+90)
  • ▲
    대량보유자Executives
    €5.9Mest.0DART
    703,717 sharesKRXDART:20251002000398
    Canonical exit: 7 Feb 2024 (T+90)
  • ▼
    대량보유자Executives
    0DART
    18,509,627 sharesKRXDART:20251002000403
  • ▼
    Related company / holdingExecutives(filed)
    €998est.0DART
    121 sharesShareKRXDART:20250930000363
  • ▼
    10%이상주주Executives(filed)
    €1,097est.0DART
    133 sharesShareKRXDART:20250930000573
  • ▼
    대량보유자Executives
    0DART
    18,830,908 sharesKRXDART:20250930000395
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    Executives
    €3.5Mest.0DART
    703,717 sharesKRXDART:20231116000484
    Canonical exit: 7 Feb 2024 (T+90)
  • ▼
    -Executives
    0DART
    ShareKRXDART:20231116000500
  • ▼
    -Executives
    0DART
    ShareKRXDART:20231116000505
  • ▼
    -Executives
    0DART
    ShareKRXDART:20231116000495
  • ▼
    -Executives
    0DART
    ShareKRXDART:20231116000491
  • ▼
    -Executives
    0DART
    ShareKRXDART:20231115000156
  • ▼
    -Executives
    0DART
    ShareKRXDART:20231115000161
  • ▼
    -Executives
    0DART
    ShareKRXDART:20231030000339
  • ▼
    -Executives
    0DART
    ShareKRXDART:20231030000348
  • ▼
    -Executives
    0DART
    ShareKRXDART:20231030000321
  • ▼
    -Executives
    0DART
    ShareKRXDART:20231027000287
  • ▼
    -Executives
    0DART
    ShareKRXDART:20231027000306

25 of 68 declarations

About 메디포스트

메디포스트 is a company in the health and pharmaceutical sector, listed on the XKRX. It focuses on the development of cell therapies and biopharmaceutical products.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations